A detailed history of Riversedge Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Riversedge Advisors, LLC holds 2,617 shares of MRK stock, worth $334,243. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,617
Previous 2,484 5.35%
Holding current value
$334,243
Previous $270,000 27.78%
% of portfolio
0.09%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$113.24 - $131.95 $15,060 - $17,549
133 Added 5.35%
2,617 $345,000
Q4 2023

Jan 17, 2024

BUY
$100.18 - $109.02 $248,847 - $270,805
2,484 New
2,484 $270,000
Q2 2023

Jul 13, 2023

BUY
$108.61 - $118.38 $195,389 - $212,965
1,799 New
1,799 $207,000
Q4 2022

Jan 20, 2023

BUY
$87.44 - $112.11 $163,163 - $209,197
1,866 New
1,866 $0

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Riversedge Advisors, LLC Portfolio

Follow Riversedge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riversedge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riversedge Advisors, LLC with notifications on news.